Previous close | 43.86 |
Open | 43.67 |
Bid | 37.04 x 100 |
Ask | 43.81 x 100 |
Day's range | 42.38 - 44.50 |
52-week range | 29.24 - 53.05 |
Volume | |
Avg. volume | 467,527 |
Market cap | 2.116B |
Beta (5Y monthly) | 1.73 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.07 |
Earnings date | 08 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 53.90 |
With the business potentially at an important milestone, we thought we'd take a closer look at Vericel Corporation's...
Director ZERBE ROBERT L MD has sold 3,278 shares of Vericel Corp (NASDAQ:VCEL) on March 27, 2024, according to a recent SEC filing.
This land developer stock hit a new high and is in a buy zone. A burn treatment biotech stock reached a high and gained 47% this year.